Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Drug Regulator MHRA Imposes More Xeljanz Use Limitations in October 2021

October 14, 2021 By Law Offices of Thomas J. Lamb, P.A.

In this Drug Safety Update document, “Tofacitinib (Xeljanz▼): new measures to minimise risk of major adverse cardiovascular events and malignancies”, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) took new regulatory action regarding the Xeljanz risk of cardiovascular events as well as the Xeljanz risk of cancers, or … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancer, cardiovascular events, Xeljanz

Xeljanz: Heart Attacks, Strokes, Cancers, Blood Clots, and Deaths – Updated FDA Warnings 2021

September 7, 2021 By Law Offices of Thomas J. Lamb, P.A.

On September 1, 2021, we saw new FDA Xeljanz warnings about the increased risks of heart attacks, strokes, cancer, blood clots, and deaths. These Xeljanz drug safety problems have been associated with all doses of Xeljanz (5 mg tablet and 10 mg tablet) and Xeljanz XR (11 mg tablet and 22 mg tablet). This September 2021 document, “FDA requires … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancer, Heart Attacks, heart problems, Strokes, Xeljanz

Johnson & Johnson Recalls Neutrogena and Aveeno Sunscreen Over Benzene Contamination Concerns

August 3, 2021 By Law Offices of Thomas J. Lamb, P.A.

As previously mentioned in our June 2021 article, "Are Benzene Contaminated Sunscreens Safe to Use?", popular sunscreen manufacturer, Johnson & Johnson has issued a voluntary recall of five Neutrogena and Aveeno aerosol sunscreen products. According to the Food and Drug Administration (FDA)'s July 2021 Safety Notice, the company conducted … [Read more...]

Filed Under: Benzene Tagged With: AML, benzene, benzene cancers, benzene contaminated sunscreen, benzene contamination, benzene exposure, cancer, MDS, sunscreen

FDA Advisory Committee Meeting Could Review Risk/Benefit Profiles for All JAK Inhibitors

July 8, 2021 By Law Offices of Thomas J. Lamb, P.A.

The FDA has delayed its decision for Abbvie’s applications to have Rinvoq approved for the additional indications of psoriatic arthritis and ankylosing spondylitis, apparently due to possible new JAK inhibitors heart side effects and cancer risks issues identified in connection with a Xeljanz safety signal. From this June 25, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancer, Heart Attacks, Rinvoq, Strokes, Xeljanz

Are Benzene Contaminated Sunscreens Safe to Use?

June 23, 2021 By Law Offices of Thomas J. Lamb, P.A.

Since our March 2021 article, "Testing Shows High Levels of Benzene Found In Hand Sanitizers", more research has shown the carcinogen benzene contaminated 78 different sunscreens and sun care products. Benzene is a chemical that has been used in many different industries, but prolonged exposure to the chemical is known to cause acute myelogenous … [Read more...]

Filed Under: Benzene Tagged With: AML, benzene, benzene cancers, benzene contaminated sunscreen, benzene contamination, benzene exposure, cancer, MDS, sunscreen

Possible FDA Advisory Committee Meeting for Xeljanz, Olumiant, and Rinvoq in Future

April 20, 2021 By Law Offices of Thomas J. Lamb, P.A.

Based on these several recent developments, we expect that there will be an FDA Advisory Committee Meeting for Xeljanz, Olumiant, and Rinvoq in the months to come. The focus of such will likely be these adverse drug events and side effects related to the JAK inhibitors class of drugs: Heart AttacksMyocardial Infarction (MI)Strokes — Ischemic / … [Read more...]

Filed Under: Unsafe Drugs Tagged With: cancer, heart problems, Olumiant, Rinvoq, Xeljanz

Are Heart Problems and Cancers JAK Inhibitors Drug Class Safety Issues?

March 30, 2021 By Law Offices of Thomas J. Lamb, P.A.

Since the February 2021 FDA alert about Xeljanz-associated heart problems and possible Xeljanz-related cancers was issued, we have been watching for any related drug safety developments concerning Olumiant and Rinvoq. The reason being there has been some concern that those adverse drug events and side effects risks may apply to those other two … [Read more...]

Filed Under: Uncategorized, Unsafe Drugs Tagged With: cancer, heart problems, JAK inhibitors, Olumiant, Rinvoq, Xeljanz

New Data Released on Risk of Lymphoma Due to Breast Implants

January 9, 2018 By Law Offices of Thomas J. Lamb, P.A.

Recent Study on BIA-ALCL RisksSince my last article on this topic, "What is the Risk of Death Due to Breast Implant-Associated Lymphoma?," additional information on the risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been released. The most recent study, titled "Breast Implants and the Risk of Anaplastic Large-Cell … [Read more...]

Filed Under: Unsafe Medical Devices Tagged With: ALCL, anaplastic large cell lymphoma, BIA-ALCL, blood cancer, breast implant-associated anaplastic large cell lymphoma, breast implants, cancer, FDA, JAMA, JAMA oncology journal, lawsuits, lymphoma, non-hodgkin lymphoma, smooth breast implants, T-cell lymphoma, textured breast implants

Breast Implant-Associated Lymphoma Diagnoses on the Rise

October 19, 2017 By Law Offices of Thomas J. Lamb, P.A.

On October 18, 2017, the JAMA Surgery journal published an article titled "Breast Implant–Associated Anaplastic Large Cell Lymphoma A Systematic Review," in which they discuss the rate of occurrence of the condition. The article served as a review of 115 articles on the topic of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) … [Read more...]

Filed Under: Unsafe Medical Devices Tagged With: ALCL, anaplastic large cell lymphoma, BIA-ALCL, blood cancer, breast implant-associated anaplastic large cell lymphoma, breast implants, cancer, FDA, JAMA, JAMA surgery journal, lawsuits, lymphoma, non-hodgkin lymphoma, smooth breast implants, T-cell lymphoma, textured breast implants

Breast Implants and Lymphoma: Who’s to Blame?

May 15, 2017 By Law Offices of Thomas J. Lamb, P.A.

As previously discussed in my articles, "Breast Implants Linked to Rare Lymphoma Blood Cancer" and "Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable, the FDA recently updated their 2011 report of the association between breast implants and anaplastic large-cell lymphoma (ALCL), providing additional information on this rare form of … [Read more...]

Filed Under: Unsafe Medical Devices Tagged With: ALCL, anaplastic large cell lymphoma, BIA-ALCL, blood cancer, breast implant-associated anaplastic large cell lymphoma, breast implants, cancer, FDA, lawsuits, lymphoma, non-hodgkin lymphoma, smooth breast implants, T-cell lymphoma, textured breast implants

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.